Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GLP-1 medications require refrigeration
Overall, that amounted to $173 billion in medical expenditures
Brain Activation Studies Neuroanatomical studies using c-Fos immunoreactivity (a marker of neuronal activation) mapped PT-141s central effects: Activation concentrated in hypothalamic nuclei including mPOA, paraventricular nucleus, and arcuate nucleus Limbic system activation in regions processing reward and motivation Dose-dependent activation patterns correlating with behavioral responses Selective activation in regions known to control sexual function across species Clinical Translation Gap: Despite robust preclinical evidence and successful Phase 3 trials in women, PT-141 currently has FDA approval only for premenopausal women with HSDD
Description FOXO4-DRI 5 mg Cell-SenescenceTargeting Peptide for Aging & Stress-Response Research FOXO4-DRI is a synthetic peptide designed to interfere with FOXO4p53 interactions in experimental models of cellular senescence
27025-41-8 Appearance Solid Molecular Weight 612.63 Formula C 20 H 32 N 6 O 12 S 2 Color White to off-white Synonyms L-Glutathione oxidized
The FAK-paxillin cell signaling pathway, which governs how cells migrate to injury sites and survive there, is upregulated by BPC-157, meaning the body sends repair cells to the damaged area more efficiently and keeps them active for longer
US$ 27.87
US$ 27.96
US$ 25.92
US$ 29.34
US$ 25.84
US$ 22.42
US$ 26.24
US$ 21.67
